An interventional study of fractional carbon dioxide laser with platelet rich plasma and fractional carbon dioxide laser with NS in Acne Scar, sponsored by Seoul National University Hospital. Completed at 1 site in Korea, Republic of. Open to participants aged 19 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-03-24.
Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Treatment
Investigation of Clinical Effect of Platelet Rich Plasma Combined With Laser on Acne Scar
Platelet Rich Plasma may relieve the adverse effect of laser treatment. and it can be expected to improve acne treatment result.
307 studies on the registry are indexed under Cicatrix; 50 are open to participants now.
This study's enrollment of 29 is below the median of 39 across 251 interventional studies indexed under Cicatrix.
Browse Cicatrix studies →Seoul National University Hospital is the lead sponsor of 1,860 studies on the registry; 275 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
fractional carbon dioxide laser followed by intradermal injection of platelet rich plasma
Procedure: fractional carbon dioxide laser with platelet rich plasma
fractional carbon dioxide laser followed by intradermal injection of NS
Procedure: fractional carbon dioxide laser with NS
fractional carbon dioxide laser followed by platelet rich plasma injection
Also known as: COFRAX with autologous PRP
fractional carbon dioxide laser followed by normal saline injection
Also known as: COFRAX with normal saline
Global assessment of acne scar
5-point grading of acne scar
Time frame: 12 weeks
ECCA (échelle d'évaluation clinique des cicatrices d'acné)
quantitative analysis of acne scar
Time frame: 12 weeks
adverse effect assessment
adverse effect assessment - erythema index, Epithelization Scale (0-12 point)
Time frame: 12 weeks
This study is completed, as verified in Jul 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seoul National University Hospital